Nascent Biomed

Delhi, India Founded: 2009 • Age: 17 yrs
Manufactures and markets a variety of pharmaceutical products for healthcare needs.

About Nascent Biomed

Nascent Biomed is a Healthcare company based in Delhi (India) founded in 2009. It manufactures and markets a variety of pharmaceutical products for healthcare needs. It operates on a B2B model. Its Indian entity Helax Probic Private Limited reported revenue of β‚Ή16.4 Lakh. Its focus areas include Pharmaceuticals, Manufacturing and Drug Marketing. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.

Company details

Nascent Biomed, established in 2009, excels in providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and drug marketing. Manufactures and markets a variety of pharmaceutical products for healthcare needs. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

Key Metrics
  • Annual Revenue
    ₹16.4 Lakh

    FY 2024 · +141% YoY

  • Net Loss
    -₹10.2 Lakh

    FY 2024 · -62% margin

  • EBITDA
    -₹9.9 Lakh

    FY 2024 · -60% margin

Board of directors of Helax Probic Private Limited (Nascent Biomed)

Helax Probic Private Limited is the primary company behind Nascent Biomed. The board of Helax Probic Private Limited currently have 3 directors; the longest-serving is Mahesh Sharma, appointed in 2011. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Mahesh Sharma
DIN 03392748
Director15 Dec 201114 yrs 10 moHelax Probic Private Limited
Suresh Sharma
DIN 03628406
Director15 Dec 201114 yrs 10 moHelax Probic Private Limited
Vijayant Jain
DIN 07155246
Director11 Apr 201511 yrs 6 moHelax Probic Private Limited

Financials of Nascent Biomed

Figures of Helax Probic Private Limited, the primary company behind Nascent Biomed, for FY 2024. Revenue was ₹16.4 Lakh (+141% year on year). Net loss was -₹10.2 Lakh (-62% margin). EBITDA was -₹9.9 Lakh (-60% margin). Revenue has grown at a compounded annual rate of +176% over three years and -11% over five years.

  • ₹16.4 LakhRevenue · FY 2024 · +141% YoY
  • -₹10.2 LakhNet loss · -62% margin
  • -₹9.9 LakhEBITDA · -60% margin
  • ₹1 LakhPaid-up capital
  • +176%Revenue CAGR, 3 years
  • -11%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Helax Probic Private Limited are on its company page.

Premium access

Detailed financial statements for Nascent Biomed

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Nascent Biomed

Nascent Biomed has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
enterohealthcare.com2018Mumbai, India$59.67M817
India's leading healthcare products distribution platform
keimed.com2000Hyderabad, India$16.62M588
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed.
sandor.co.in1995Hyderabad, India$8.98M161
Provider of medical equipment, devices, and drugs distribution services
Premium access

Detailed similar companies of Nascent Biomed

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Nascent Biomed

Nascent Biomed was founded in 2009.

Nascent Biomed is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

The primary company behind Nascent Biomed, Helax Probic Private Limited, reported revenue of β‚Ή16.4 Lakh for FY 2024, up 141% year on year.

Nascent Biomed, established in 2009, excels in providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and drug marketing. Manufactures and markets a variety of pharmaceutical products for healthcare needs. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

Nascent Biomed's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.

Nascent Biomed operates through Helax Probic Private Limited.

The legal entities of Nascent Biomed currently have 3 directors, including Vijayant Jain, Mahesh Sharma, Suresh Sharma.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available